BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191211
DTEND;VALUE=DATE:20191212
DTSTAMP:20191117T030306Z
CREATED:20191117T023811Z
LAST-MODIFIED:20191117T030306Z
UID:34095-1576022400-1576108799@globalbiodefense.com
SUMMARY:DARPA DIGET Proposers Day - Detect It with Gene Editing Technologies
DESCRIPTION:The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Proposers Day for the potential proposer community in support of a planned Broad Agency Announcement (BAA) for the DIGET (Detect It with Gene Editing Technologies) Program. \nThe Proposers Day will be held on December 11\, 2019 from 8:00 AM to 6:00 PM ET at the Hyatt Regency in Atlanta\, GA. \nThe DoD requires timely and comprehensive threat detection to support overall readiness\, counter the spread of disease\, and promote stabilization missions. The DIGET program aims to deliver this capability\, leveraging advances in gene editing technologies to develop low-cost\, high-trust\, rapidly reconfigurable\, and fieldable diagnostic (Dx) and biosurveillance (BSV) technologies to enable detection of any threat\, anytime\, anywhere. \nThe Proposers Day goals include:\n1. Introduce the DIGET program vision and goals;\n2. Explain the mechanics of a DARPA program in general and the objectives and milestones\nof this program in particular; and\n3. Encourage and promote teaming arrangements among organizations that have the relevant\nexpertise\, research facilities\, and capabilities for executing research and development\nresponsive to the DIGET program goals. \nThe Proposers Day will include brief overview presentations by government personnel as well as\nan information session to respond to questions from participants. Potential performers can\nhighlight their technical capabilities through “lightning” talks such that teaming relationships can\nbe developed. Lightning talk presentations will be made accessible to the proposer community on\nthe DIGET program website after presentation at the Proposers Day. It is expected that DIGET\nwill require strong teaming efforts to successfully innovate and integrate critical technologies\nnecessary to meet the metrics of the program. Private sidebar meetings with the DARPA\ngovernment team and potential proposer teams can be scheduled beforehand on the registration\nwebsite. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding.\nInformation relayed during the Proposers Day will be made available on the BTO section of the\nDARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nInterested attendees are invited to present a brief one-slide PowerPoint summary of their interests\, capabilities\, and teaming goals. Speakers will be allowed 3 minutes for discussion during a\n“lightning” presentation session at Proposers Day. Presentations consisting of multiple slides will\nnot be granted a time slot. Requests for lightning talks and sidebar meetings will be accepted on\na first-come basis. All presentations must be emailed to DARPA-SN-20-12@darpa.mil\nno later than 12:00 PM ET on December 2\, 2019. Specific content\, communications\, networking\,\nand team formation are the sole responsibility of the participants. \nRegistration Information:\nPLEASE NOTE: Registration closes on December 2\, 2019 at 12:00 PM ET. \nRegistration is limited by the venue capacity\, and early registration is strongly recommended. The\nregistration cutoff date is December 2\, 2019 at 12:00 PM EST\, or once attendance capacity is met\,\nwhichever comes first. There will be no on-site registration. \nParticipants must register in advance through the registration website. There will be a $25\nregistration fee for the Proposers Day. Early registration is strongly recommended. Due to space\nlimitations\, attendance for the Proposers Day will be limited to the first 150 registrants. Interested\nparties are encouraged to coordinate attendance internally within their organizations prior to\nregistration. Attendance is limited to no more than two representatives per division/department.\nIndividuals that are unable to register because the deadline has occurred or capacity has been\nreached will be added to a waitlist. If slots remain open after registration closes or become\navailable due to cancellations\, the slots will be filled on a first-come\, first-serve basis from the\nwaitlist. An online registration form and various other meeting details can be found at the\nregistration website: https://events.sa-meetings.com/DIGETProposersDay. \nPotential proposing teams are not required to attend Proposers Day\, although participation is\nstrongly encouraged. \n\n\n\n\nContact Information\nPlease direct all questions to DARPA-SN-20-12@darpa.mil and refer to the DIGET Proposers Day (DARPA-SN-20-12) in all correspondence. \nGlobal Biodefense is a news publication and not directly responsible for this event. Information is subject to change. Please contact the event organizers for the most up-to-date information.
URL:https://globalbiodefense.com/event/darpa-diget-proposers-day/
LOCATION:Hyatt Regency Atlanta\, 265 Peachtree street NE\, Atlanta\, 30303\, United States
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200114
DTEND;VALUE=DATE:20200116
DTSTAMP:20200115T041521Z
CREATED:20191201T155453Z
LAST-MODIFIED:20200115T041521Z
UID:34798-1578960000-1579132799@globalbiodefense.com
SUMMARY:Ultraviolet Disinfection Technologies & Healthcare Associated Infections
DESCRIPTION:The National Institute of Standards and Technology (NIST) is co-hosting a 2-day meeting with the International Ultra Violet Association (IUVA) focused on examining measurement\, standards\, technology and data research needs to promote innovation in the effective use and implementation of ultraviolet-C (UVC) technology in healthcare settings for the reduction and prevention of healthcare associated infections (HAIs). \nThis unique event provides the community with an opportunity to learn about the current science in HAI prevention with UVC and to discuss standard needs in both the physical and biological performance areas for UVC disinfection devices. \nHAIs are recognized as an important public health and patient safety issue. UVC devices are shown to reduce the incidence of many HAIs\, but the adoption of the technology by the healthcare industry has been sparse. There is a lack of performance standards to help healthcare managers make informed\, credible investment decisions. Measurements and standards in the light and biological sciences are needed to accelerate the adoption of UVC technology in the healthcare market. \nThrough two days of targeted programming\, attendees will learn about the latest developments in UVC technology\, engineering and operations\, and regulatory issues related to disinfection. Current measurements\, standards and data supporting UVC disinfection will be discussed in the context of innovation and implementation. Input from the event will be used by the community for the development of proposed performance standards for UVC disinfection devices. \nProgramming will include plenary presentations from invited keynote subject matter experts and round table engagements with representatives from industry\, academia and federal agencies. There will be optional campus lab tours where attendees can view up-close NIST’s metrology R&D in the UV and biological sciences\, including UV calibrations and biological measurements. \nRegistration contact: Karen M. Startsman\, karen.startsman@nist.gov (301) 975-6602 \nEditor’s note (1 Dec 2019): Registration is expected to open shortly.  Please check this website for the latest information updates. Once registration is open\, it is expected to remain open until Tuesday\, January 7\, 2020.
URL:https://globalbiodefense.com/event/ultraviolet-disinfection-technologies-healthcare-associated-infections/
LOCATION:National Institutes of Standards and Technology (NIST)\, 100 Bureau Drive\, Gaithersburg\, MD\, 20899\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/12/ultra-violet-disinfection-hai-healthcare-associated-infections.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200123
DTEND;VALUE=DATE:20200125
DTSTAMP:20200105T182855Z
CREATED:20191205T175457Z
LAST-MODIFIED:20200105T182855Z
UID:36104-1579737600-1579910399@globalbiodefense.com
SUMMARY:National Science Advisory Board for Biosecurity (NSABB) Meeting
DESCRIPTION:The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda\, Md. \nThe meeting will be open to the public\, with attendance limited to space available. The meeting will also be videocast. \nJanuary 23: 12:30 PM – 5 PM Eastern\nJanuary 24: 9 AM – 2:30 PM Eastern \nThe purpose of this meeting is to discuss considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; as well as other business of the Board. \nIf you plan to attend the meeting in person please pre-register HERE.\nIndividuals in attendance may also register onsite on the day of the meeting.\nDraft Agenda will be posted when available. \nVideocasts: \n\nDay 1 – Link will be available on January 23\, 2020\nDay 2 – Link will be available on January 24\, 2020\n\nPlease visit the website for more information: http://bit.ly/NSABB-Meetings \nCurrent Voting Board Members\nMargie D. Lee\, DVM\, PhD*\nProfessor and Head\, Department of Biomedical Sciences and Pathobiology\nVirginia-Maryland College of Veterinary Medicine\nVirginia Tech \nStephen S. Morse\, PhD*\nDirector\, Infectious Disease Epidemiology Certificate Program\nProfessor of Epidemiology\nMailman School of Public Health\nColumbia University \nJean L. Patterson\, PhD\nProfessor\, Virology and Immunology Chair\, BSL-4 Task Force\nTexas Biomedical Research Institute \nRozanne M. Sandri-Goldin\, PhD\nProfessor and Chair\, Department of Microbiology and\nMolecular Genetics\nUniversity of California Irvine School of Medicine \nKenneth Bernard\, MD\nRADM\, U.S. Public Health Service (Ret.)\nFormer Special Assistant to the President for Biodefense\, Homeland Security Council\, White House\nFormer Special Adviser for Health and Security on the National Security Council \nCraig E. Cameron\, PhD\nJeffrey Houpt Distinguished Investigator\nChair\, Department of Microbiology and Immunology\nUniversity of North Carolina Chapel Hill School of Medicine \nMark Denison\, MD\nProfessor and Chair of Pediatrics\nAssociate Professor of Microbiology and Immunology\nVanderbilt University School of Medicine \nJohn D. Grabenstein\, RPh\, PhD\nSenior Medical Director\, Adult Vaccines\nMerck Vaccine Division\nMerck & Co.\, Inc. \nMarie-Louise Hammarskjöld\, MD\, PhD\nCharles H. Ross Jr. Professor and Professor of Microbiology\, Immunology\, and Cancer Biology\nAssociate Director\, Myles H. Thaler Center\nUniversity of Virginia School of Medicine \nJames W. LeDuc\, PhD\nDirector\, Galveston National Laboratory\nProfessor\, Department of Microbiology and Immunology\nUniversity of Texas Medical Branch
URL:https://globalbiodefense.com/event/national-science-advisory-board-for-biosecurity-nsabb-meeting/
LOCATION:Hyatt Regency Bethesda\, One Bethesda Metro Center\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200128
DTEND;VALUE=DATE:20200131
DTSTAMP:20200117T055633Z
CREATED:20190809T194705Z
LAST-MODIFIED:20200117T055633Z
UID:29873-1580169600-1580428799@globalbiodefense.com
SUMMARY:2020 ASM Biothreats
DESCRIPTION:The leading annual conference on biodefense\, biosecurity and biological threats\, ASM Biothreats\, will be held January 28–30\, 2020 in Arlington\, Virginia. \nHosted by the American Society for Microbiology\, this one-of-a-kind meeting draws stakeholders from government\, academia and industry for an important exchange of knowledge and ideas that will shape the future of high consequence pathogen research. \nASM Biothreats offers a unique program that explores the latest developments and emerging technologies in the industry. \nA few highlights in this year’s outstanding agenda include: \n\nSmallpox: Development and Use of the Panoply of Countermeasures in the Armamentarium\nBiomarkers for Biothreats: New Opportunities for Discovery and Verification\nResearch and Innovation to Inform Management of High Consequence Infectious Pathogens\nAggressive Measures to Develop Assays and Animal Models to Combat ZIKV Infection \nNew Developments in Antimicrobials\nFrom Surveillance to Bedside: Tools for the Next Outbreak\nBasic Vector Biology Research to Combat Vector-borne Diseases\nImmune Correlates of Protection for Vaccines against Biothreat Viruses\nEvolution of Biothreat Viruses\nIntracellular Bacteria – Pathogenesis and Countermeasures\nInnovations in Biothreat Detection\nInternational Collaboration without Complications and Confusion\nVaccine Development Efforts Against Bacterial Biothreats\n\nPlease visit the ASM Biothreats 2020 website to register. \nGlobal Biodefense is an official media partner of ASM Biothreats.
URL:https://globalbiodefense.com/event/2020-asm-biothreats/
LOCATION:Hyatt Regency Crystal City\, 2799 Jefferson Davis Highway\, Arlington\, VA\, 22202\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/asm-biothreats-2020-lg-bnr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T083000
DTEND;TZID=America/New_York:20200203T170000
DTSTAMP:20200115T031436Z
CREATED:20191115T030617Z
LAST-MODIFIED:20200115T031436Z
UID:37038-1580718600-1580749200@globalbiodefense.com
SUMMARY:Advancing EUA IVD Products Toward Full Marketing Status
DESCRIPTION:The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. \nA roadmap for diagnostic evaluations during emergencies would help enable stakeholders to have templates to use to expedite evaluation of laboratory-based tests and point of care technologies. By convening a broad range of government and industry stakeholders\, the goal of the workshop is: \nTo identify challenges and next steps to the use of RWD/RWE to help support the advancement of EUA IVD products to full marketing status. \nThe projected outcomes of the workshop include: \n\nIdentify test case(s) of interest to stakeholders\nDiscussion to inform development of a roadmap for diagnostic evaluations during emergencies\, to include what elements to collect (and how)\nIdentify potential projects or next steps for the test case(s) of interest\n\nKeynote Speakers: \n\nLuciana Borio\, MD; Vice President\, Technical Staff | In-Q-Tel\nNira Pollock\, MD\, PhD; Assoc Medical Director of Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital\, faculty member of the Division of Infectious Diseases at Beth Israel Deaconess Medical Center\, Boston\, MA.\n\nFDA Speakers: \n\nRADM Denise Hinton\, FDA Chief Scientist\nTimothy Stenzel\, MD\, PhD\, Director\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH\nUwe Scherf\, M.Sc.\, PhD\, Director\, Division of Microbiology Devices\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH
URL:https://globalbiodefense.com/event/advancing-eua-ivd-products-toward-full-marketing-status/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200206T173000
DTEND;TZID=America/New_York:20200206T190000
DTSTAMP:20200206T190217Z
CREATED:20200203T163455Z
LAST-MODIFIED:20200206T190217Z
UID:38437-1581010200-1581015600@globalbiodefense.com
SUMMARY:Yale Forum on Outbreak of Novel Coronavirus
DESCRIPTION:In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China\, the Yale Institute for Global Health\, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday\, February 6\, 2020. Panelists will address the epidemiology of the disease\, its impact on public health\, human rights issues and how information on such outbreaks is communicated to the public.\n\nModerator \nSaad Omer\, Director\, Yale Institute for Global Health; Professor of Medicine (Infectious Diseases)\, Yale School of Medicine; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases\, Yale School of Public Health \nPanelists \nEllen Foxman\, Assistant Professor of Laboratory Medicine and Immunobiology\, Yale School of Medicine \nGregg Gonsalves\, Assistant Professor of Epidemiology; Associate (Adjunct) Professor of Law\, Yale Law School; Co-Director\, Global Health Justice Partnership \nNathan Grubaugh\, Assistant Professor of Epidemiology (Microbial Diseases)\, Yale School of Public Health \nLisa Sanders\, Associate Professor of Medicine (General Medicine)\, Yale School of Medicine; Emmy-award winning television producer\, author of The New York Times column Diagnosis \nDavid Vlahov\, Professor\, PhD Program Director\, Yale School of Nursing \nLive Stream Link \nhttps://yale.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=50702300-d8eb-4398-9d9e-ab530102bbbe
URL:https://globalbiodefense.com/event/yale-forum-on-outbreak-of-novel-coronavirus/
LOCATION:Winslow Auditorium\, 60 College Street\, LEPH 109\, New Haven\, CT\, 06510\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T133000
DTEND;TZID=America/New_York:20200210T153000
DTSTAMP:20200203T162053Z
CREATED:20200203T161203Z
LAST-MODIFIED:20200203T162053Z
UID:38397-1581341400-1581348600@globalbiodefense.com
SUMMARY:Containing the Coronavirus: Challenges to Thwarting the Outbreak
DESCRIPTION:Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. \nConfirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic\, with thousands more suspected cases. As the number of cases increases\, concerns are mounting that the global community may not be adequately prepared to prevent the disease from significantly spreading. \nThe virus has already spread to more than 20 countries\, including the United States\, with at least six confirmed cases and more than 100 suspected across 36 states. The Center for Disease Control (CDC) is screening passengers arriving from China at several airports\, but much remains unknown about transmission and symptoms\, and a CDC-developed diagnostic test has yet to be distributed across the country. \nPanel participants will offer their perspectives on the role of the federal government in managing the crisis\, the lack of transparency by the Communist Chinese Government\, implications for U.S national security\, and how the country can better prepare for when the next pandemic strikes. \nThe event will feature U.S. Senator Joe Lieberman\, co-chair of the Bipartisan Commission on Biodefense\, scholars from Hudson Institute\, and other subject matter experts. \nNOTE: This event is open to the press. All members of the media should RSVP to press@hudson.org.
URL:https://globalbiodefense.com/event/containing-the-coronavirus-challenges-to-thwarting-the-outbreak/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200210T150000
DTEND;TZID=America/Los_Angeles:20200210T170000
DTSTAMP:20200203T162654Z
CREATED:20200203T162525Z
LAST-MODIFIED:20200203T162654Z
UID:38426-1581346800-1581354000@globalbiodefense.com
SUMMARY:The Novel Coronavirus: What Do We Know and What's Next?
DESCRIPTION:The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What’s Next?\, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan\, China in December 2019. On January 30\, 2020\, the WHO declared the outbreak a public health emergency of international concern. To address what we know and what’s next\, join Ron Brookmeyer\, dean of the UCLA Fielding School of Public Health\, and Michael Berry\, director of the UCLA Center for Chinese Studies\, in conversation with: \n\nRoger Detels\, professor\, UCLA Fielding School of Public Health\nAnne Rimoin\, professor\, UCLA Fielding School of Public Health\nAlex Wang\, professor\, UCLA School of Law\nOtto Yang\, professor\, Geffen School of Medicine at UCLA\nZuo-Feng Zhang\, professor\, UCLA Fielding School of Public Health\n\nFor more information\, including how to join the symposium via livestream\, please visit \nhttps://ph.ucla.edu/events/novel-coronavirus-what-do-we-know-and-whats-next
URL:https://globalbiodefense.com/event/the-novel-coronavirus-what-do-we-know-and-whats-next/
LOCATION:Neuroscience Research Building (NRB)\, 635 Charles E Young Drive South\, Los Angeles\, CA\, 90095\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/f34d7fcec7626144b08868be30aa3139-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200211
DTEND;VALUE=DATE:20200213
DTSTAMP:20200209T193131Z
CREATED:20200209T192624Z
LAST-MODIFIED:20200209T193131Z
UID:39221-1581379200-1581551999@globalbiodefense.com
SUMMARY:WHO Global Research and Innovation Forum: 2019-nCoV Emergency
DESCRIPTION:The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. \nThe event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)\, and brings together key players including leading scientists as well as public health agencies\, ministries of health and research funders pursuing 2019-nCoV critical research and the development of vaccines\, therapeutics and diagnostics\, among other innovations. \nThe WHO R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of\nR&D activities during epidemics. Its aim is to fast-track the availability of effective tests\, vaccines and\nmedicines that can be used to save lives and avert large scale crisis. \nThe global imperative for research is to maintain a high-level discussion platform which enables\nconsensus on strategic directions\, nurtures scientific collaborations and\, supports optimal and rapid\nresearch to address crucial gaps\, without duplication of efforts. \nUnderstanding the disease\, its reservoirs\, its transmission\, its clinical severity and developing effective\ncounter measures is critical for the control of the outbreak\, the reduction of related mortality and\nminimization of economic impact. \nPurpose\nTo enable identification of key knowledge gaps\, and research priorities and thereby accelerate the\ngeneration of critical scientific information and the most needed medical products to contribute to\nthe control the 2019-nCoV emergency. \nExpected outcome\nA research roadmap with clearly defined priorities and governance framework addressing each of\nseveral thematic areas will be considered at the meeting\, namely: virus\, diagnostics; natural history\nand transmission; clinical; therapeutics; vaccines; ethics; regulatory science; animal health;\ndata/samples analysis and sharing and; social sciences. \nAttendees\nThe participants will include diverse multi-disciplinary teams:\n• Member States representatives from countries with cases\n• Representatives from the scientific community and public health agencies\n• Regulatory experts\n• Bioethicists with expertise in emergencies\n• Major funders of research\nWHO is delighted to welcome y
URL:https://globalbiodefense.com/event/who-global-research-and-innovation-forum-2019-ncov-emergency/
LOCATION:WHO Headquarters\, Geneva\, Switzerland
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200219T170000
DTEND;TZID=America/Toronto:20200219T191500
DTSTAMP:20200203T162738Z
CREATED:20200203T162443Z
LAST-MODIFIED:20200203T162738Z
UID:38421-1582131600-1582139700@globalbiodefense.com
SUMMARY:2019-nCoV Update for  Health Care Providers
DESCRIPTION:Target Audience: Health care providers (including primary care physicians & nursing professionals)\n\n\n\nKey Note Speakers: \n\nDr. Gerald Evans Chair of the Division of Infectious Diseases\, Professor of Medicine\, Queens University; Attending Staff\, Kingston Health Sciences Centre\nDr. Piotr Oglaza Medical Officer of Health & CEO\, Hastings Prince Edward Public Health\nYvonne DeWit\, Epidemiologist\, Hastings Prince Edward Public Health\nMorgan Harnest\, Infection Control Lead\, PHN\, Hastings Prince Edward Public Health\n\nTopics: \n\nThe 2019 novel coronavirus\nEpidemiology\nPublic Health Response\nPersonal Protective Equipment\nWhat’s New\n\nRegistration is required. A light dinner will be provided. Please let us know if you have any dietary restrictions. \nPlease register by February 17th\, 2020.
URL:https://globalbiodefense.com/event/2019-ncov-update-for-health-care-providers/
LOCATION:Hastings Prince Edward Public Health\, 179 North Park Street\, Belleville\, ON\, K8P 4P1\, Canada
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/8f447dac25fd3022c25eafa4210f5a82.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200227T140000
DTEND;TZID=America/New_York:20200227T160000
DTSTAMP:20200220T230510Z
CREATED:20200220T225626Z
LAST-MODIFIED:20200220T230510Z
UID:40056-1582812000-1582819200@globalbiodefense.com
SUMMARY:Coronavirus Disease 2019: The U.S. and International Response
DESCRIPTION:The House Foreign Affairs Subcommittee on Asia\, the Pacific\, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. \nWitnesses will include U.S. government officials who have led the response to the virus. \nDate: Thursday\, February 27\, 2020 \nTime: 2:00 p.m. EST \nSubject: Coronavirus Disease 2019: The U.S. and International Response \nWitnesses: \n\nMr. Ian Brownlee\nPrincipal Deputy Assistant Secretary\, Bureau of Consular Affairs\, U.S. Department of State \nMr. Jonathan Fritz\nDeputy Assistant Secretary\, Bureau of East Asian and Pacific Affairs\, U.S. Department of State \nWilliam A. Walters\, Ph.D.\nExecutive Director and Managing Director for Operational Medicine\, Bureau of Medical Services\, U.S. Department of State \nRobert Redfield\, Ph.D.\nDirector\, U.S. Centers for Disease Control and Prevention
URL:https://globalbiodefense.com/event/coronavirus-disease-2019-the-u-s-and-international-response/
LOCATION:Rayburn House Office Building\, Washington\, DC\, United States
CATEGORIES:Conference,Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200228T140000
DTEND;TZID=Europe/London:20200228T170000
DTSTAMP:20200203T163127Z
CREATED:20200203T162156Z
LAST-MODIFIED:20200203T163127Z
UID:38406-1582898400-1582909200@globalbiodefense.com
SUMMARY:Faculty of Natural Sciences Research Seminar: Infectious Diseases
DESCRIPTION:Join the next FoNS Research Seminar and learn the cutting-edge research on infectious diseases taking place across the Faculty\n\n\n\nThe Faculty regularly organises events that showcase its strong research areas in order to stimulate new collaborations and discussions around a topic. The next one will be on the topic of “Infectious Diseases”. Our highlighted speakers are: \n\nProf. Ed Tate\, Professor in Chemical Biology\, Department of Chemistry\n\n\nDr Anna Barnard\, Sir Henry Dale Fellow\, Department of Chemistry\n\n\nDr Abigail Clements\, Lecturer\, Department of Life Sciences\n\n\nDr Gerald Larrouy-Maumus\, Senior Lecturer\, Department of Life Sciences\n\n\nDr Oliver Ratmann\, Lecturer in Statistics\, Department of Mathematics\n\nPhD students and postdocs will also participate at this event and their names will be announced very soon. Note there will be a drinks & canapes reception afterwards! \nFor further details about this event\, please see the event’s website.
URL:https://globalbiodefense.com/event/faculty-of-natural-sciences-research-seminar-infectious-diseases/
LOCATION:Imperial College London\, Sir Alexander Fleming Building G34 LT\, Exhibition Road\, London\, SW7 2AZ\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/89a4e54954d51d64e4de06a176f38c9a.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200229
DTEND;VALUE=DATE:20200305
DTSTAMP:20200210T165602Z
CREATED:20200210T162700Z
LAST-MODIFIED:20200210T165602Z
UID:39241-1582934400-1583366399@globalbiodefense.com
SUMMARY:16th CDC International Symposium on Biosafety
DESCRIPTION:The 16th CDC International Symposium on Biosafety – Laboratory Safety and Security for Clinical\, Public Health\, Research and Animal Care will be held 29 February – 4 March\, 2020 in Atlanta\, Georgia. \nStakeholders will learn about the soon-to-be-released 6th edition of the BMBL\, gaps in clinical and research biosafety\, risk management tools for animal facilities\, virtual reality training\, poliovirus containment\, and more. \nHighlighted sessions include: \n\nExperiences Coordinating Laboratory Policies and Procedures at CDC \nSteve Monroe\, PhD\, Centers for Disease Control and Prevention\nLaboratory Emergency Response Plans: A Team Approach\nPatrick Stockton\, MS\, RBP\, University of Georgia (Biosafety)\, Steve Harris\, University of Georgia (Emergency Preparedness)\, Captain Adam Fouche\, University of Georgia (Police)\, and Roger L. Evans\, Athens Clark County (Fire)\nLessons Learned in Risk Assessment for the Laboratory and Beyond\nRyan Ritterson\, PhD\, Gryphon Scientific\nIssues in Operation and Decontamination in Animal Research Facilities\nJason Villano\, DVM\, MSc\, MS\, DACLAM\, Johns Hopkins University \nDecontamination in the Clinical Laboratory: A Unique Environment\nSheldon Campbell\, MD\, PhD\, FCAP\, Yale School of Medicine\nUsing Risk Assessment to Identify\, Evaluate and Prioritize Facility Repairs\nJohn R. Henneman\, M.S.\, RBP/ABSA\, Biosecurity Research Institute and Miguel A. Grimaldo\, M. Eng\, University of Texas Medical Branch\n\nPlease visit the Eagleson Institute’s CDC Biosafety Symposium website for more information and to register.
URL:https://globalbiodefense.com/event/16th-cdc-international-symposium-on-biosafety/
LOCATION:Westin Perimeter North Hotel\, 7 Concourse Pkwy NE\, Atlanta\, GA\, 30328\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T113000
DTEND;TZID=America/New_York:20200302T120000
DTSTAMP:20200301T230419Z
CREATED:20200301T230209Z
LAST-MODIFIED:20200301T230419Z
UID:40566-1583148600-1583150400@globalbiodefense.com
SUMMARY:COVID-19 Live Webcast with Johns Hopkins Experts
DESCRIPTION:With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high\,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern. \nYou’ll hear from Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response. The conversation will be moderated by Dr. Joshua Sharfstein\, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health. \nThey’ll discuss the findings of the Global Health Security Index referenced by President Trump last week\, what you need to know about community transmission and how to protect yourself from misinformation. They will also answer viewer questions submitted before and during the broadcast. \nSpeakers\n\nJennifer Nuzzo\, DrPH\, SM\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nTara Kirk Sell\, PhD\, MA\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nLauren M. Sauer\, MS\nDirector of Operations\, Johns Hopkins Office of Critical Event Preparedness and Response\nJohns Hopkins University School of Medicine\nJosh Sharfstein\, MD\nModerator\nVice Dean for Public Health Practice and Community Engagement\nJohns Hopkins Bloomberg School of Public Health\n\nA recording will be made available via on The Hub’s dedicated coronavirus page at https://hub.jhu.edu/novel-coronavirus-information/ and across Bloomberg School channels. \nThe Johns Hopkins Bloomberg School of Public Health will host additional webcasts as the coronavirus outbreak continues. Follow us on Twitter\, Facebook\, LinkedIn\, and Instagram to be notified about future broadcasts. \nThe Bloomberg School is also launching a daily “Public Health On Call” podcast with an immediate focus on the coronavirus outbreak. Subscribe via YouTube or Libsyn.
URL:https://globalbiodefense.com/event/covid-19-live-webcast-with-johns-hopkins-experts/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200306
DTSTAMP:20191227T222008Z
CREATED:20191115T214342Z
LAST-MODIFIED:20191227T222008Z
UID:36020-1583193600-1583452799@globalbiodefense.com
SUMMARY:Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience
DESCRIPTION:The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5\, 2020 in Arlington\, Virginia. \nThe meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. \nThis meeting is sponsored by the DoD Blast Injury Research Coordinating Office\, U.S. Army Medical Research and Development Command\, on behalf of the DoD Executive Agent for Medical Research for Prevention\, Mitigation\, and Treatment of Blast Injuries. \nThe event is presented by the RAND National Security Research Division (NSRD)\, which conducts research and analysis for all national security sponsors other than the U.S. Air Force and the Army. The division includes the National Defense Research Institute\, a federally funded research and development center whose sponsors include the Office of the Secretary of Defense\, the Joint Staff\, the Unified Combatant Commands\, the defense agencies\, and the Department of the Navy. NSRD also conducts research for the U.S. intelligence community and the ministries of defense of U.S. allies and partners. \nThis will be a working meeting. Over 100 subject matter experts from the DoD\, other Federal agencies\, academia\, industry\, and the international community are expected to participate. \nAttendance is free\, first come-first serve\, and capped at 150. There are no continuing education credits\, and participants are responsible for their own travel\, lodging\, and expenses. \nEDITOR’S UPDATE: Registration for the Ninth State-of-the-Science Meeting is now full. If you would like to be added to the waitlist\, contact the event organizers here.
URL:https://globalbiodefense.com/event/mitigating-the-impact-of-blast-related-burn-injuries-from-prolonged-field-care-to-rehabilitation-and-resilience/
LOCATION:RAND’s Pentagon City Office\, 4th Floor\, 1200 South Hayes Street\, Arlington\, VA\, 22202-5050\, United States
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200312T130000
DTEND;TZID=America/New_York:20200312T143000
DTSTAMP:20200220T011222Z
CREATED:20200220T010949Z
LAST-MODIFIED:20200220T011222Z
UID:39863-1584018000-1584023400@globalbiodefense.com
SUMMARY:Center for the Study of WMD Spotlight Seminar: Coronavirus and Biosecurity
DESCRIPTION:The outbreak of the deadly coronavirus is the latest global health crisis to capture the headlines and the fears of the world. With daily updates from health officials\, there is both a surfeit of information and plenty of misinformation about the disease\, its spread\, and its origin. \nPlease join us at the Center for the Study of Weapons of Mass Destruction March Spotlight Seminar on “Coronavirus and Biosecurity.” The panel will feature experts in the fields of bioterrorism\, biosurveillance\, and infectious disease who can provide timely context for the outbreak. Panelists will assess the response to the public health emergency by the United States and China and discuss what this novel coronavirus may teach us for future natural and intentional biological events. \nIf you have any questions about the event\, please contact the CSWMD Admin staff at CSWMD-Admin@ndu.edu or call 202-433-6382. \nBiographies:\nDr. Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is an immunologist by training. Dr. Gronvall’s work at the Center for Health Security addresses the role of scientists in health security—how they can contribute to an effective technical response against a biological weapon or a natural epidemic. She is particularly interested in developing policies that will boost the safety and security of biological science activities while allowing beneficial research to flourish. Dr. Gronvall is the author of the books Synthetic Biology: Safety\, Security\, and Promise and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. \nDr. Noreen Hynes has more than 40 years of medical and public health experience in both international and domestic settings. She is a physician trained in internal medicine\, infectious diseases\, tropical medicine\, and epidemiology. Prior to her medical education\, Dr. Hynes served as a Peace Corps Volunteer in Tunisia\, followed by serving as a Foreign Service Officer in Mali and Cote d’Ivoire\, and then received a master of public health degree from Johns Hopkins University. After earning a medical degree from the Uniformed Services University of the Health Sciences in Bethesda\, MD\, Dr. Hynes completed a residency in internal medicine and a fellowship in infectious diseases at the Massachusetts General Hospital/Harvard Medical School. As a Commissioned Officer in the U.S. Public Health Service\, Dr. Hynes’ duty stations included Atlanta (Epidemic Intelligence Service)\, Colorado\, Arkansas\, Baltimore\, and Washington D.C. Following the events of late 2001\, she served as senior advisor to the Vice President of the United States for Medicine and Public Health (Homeland Security). Prior to retirement from government service in 2007\, Dr. Hynes was the deputy assistant secretary for Public Health Emergency Preparedness and the director of the Office of Public Health Emergency Medical Countermeasures (now the Biomedical Advanced Research and Development Authority – BARDA) at the US Department of Health and Human Services. Since 1997\, Dr. Hynes has been a part-time faculty member at the Johns Hopkins University Schools of Medicine and Public Health. She directs the Geographic Medicine Center of the Division of Infectious Diseases and serves as the associate medical director of the Biocontainment Unit of the Johns Hopkins Hospital — a unit focused on the care of patients with high consequence pathogens\, such as Ebola. At the Bloomberg School of Public Health\, Dr. Hynes co-directs the infectious diseases concentration in the master of public health program and co-teaches a course focused on the science\, public health and policy aspects of chemical and biological weapons. Her research focuses on vaccine-preventable diseases\, tropical diseases\, zoonotic infections\, and high consequence pathogens. \nDr. Rohit Chitale joined DARPA as a program manager in 2019. He is an infectious disease epidemiologist with more than 20 years of experience helping national and international organizations establish and lead programs related to infectious disease prevention and eradication\, with specific expertise in the design and implementation of disease surveillance systems and the development of new disease control tools. Before coming to DARPA\, Dr. Chitale co-established the Global Disease Detection Operations Center at the U.S. Centers for Disease Control and Prevention (CDC)\, the first event-based all-hazards surveillance unit at the CDC. He also served as the CDC Country Director in the Republic of South Sudan. In a prior role at the U.S. Department of Defense (DoD)\, he established and led the Division of Integrated Biosurveillance within the Armed Forces Health Surveillance Center to address capability gaps in DoD biosurveillance and global health security operations. In that role\, he led efforts to integrate syndromic\, case-based\, and event-based disease surveillance systems across civilian\, military\, and veteran populations to decrease the time to disease detection\, diagnosis\, and treatment. While at DoD\, he helped write the Global Health Security Agenda legislation. Previously\, at the Johns Hopkins Bloomberg School of Public Health\, Dr. Chitale co-created The MENTOR Initiative — a public-private partnership designed to test and evaluate (pre-clinical\, Phase I\, II\, and III trials) new vector-borne disease control technologies.
URL:https://globalbiodefense.com/event/center-for-the-study-of-wmd-spotlight-seminar-coronavirus-and-biosecurity/
LOCATION:National Defense University\, 300 5th Avenue SW\, Washington\, DC\, 20319\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200316
DTEND;VALUE=DATE:20200318
DTSTAMP:20200223T181226Z
CREATED:20200223T173102Z
LAST-MODIFIED:20200223T181226Z
UID:40151-1584316800-1584489599@globalbiodefense.com
SUMMARY:IABS-CEPI Vaccine Technology Platforms Meeting
DESCRIPTION:A cross-learning symposium on vaccine licensure based on technology platforms\, the IABS-CEPI-ZAPI Technology Platforms Meeting\, will take place 16-17 March 2020 in Brussels\, Belgium. \nThe scientific committee for this workshop is co-Chaired by: \n\nDaniel Brasseur\, former CHMP-PDCO-VWP chair at EMA; CEPI consultant\nMurray Lumpkin\, former Deputy Director\, FDA; Bill & Melinda Gates Foundation\n\nHighlighted topics of interest on the agenda include: \n\nWHO regulatory preparedness activities to facilitate access to emergency vaccines\nHuman influenza vaccine successes and failures\nLessons for emergency preparedness leaned from Ebola vaccine development and licensure\nRegulatory approach to vaccine tech platforms: FDA perspective\, EU approach\, AVAREF\, Asian regulators\nAdvanced human vaccines in the pipeline (viral vectors\, VSV-Measles-ChAd…) and RNA\, DNA technologies\nTo what extent can clinical trials be pre-arranged?\nDetermining what is platform generic vs. platform specific in manufacturing and quality control\nChallenges to prove vaccine efficacy for outbreak vaccines and mitigating risk\nStreamlining regulatory acceptance from ‘tried and true’ vaccine platforms\n\nIn addition\, CEPI will review its current portfolio and examples of vaccine candidates based on technology platforms. \nMembers of the Scientific Committee include: \n\nDr. Barney Graham\, NIH\, Deputy Director and Chief\, Viral Pathogenesis Laboratory\nDr. Mélanie Saville\, Director\, Vaccine Development\, CEPI\nProf. Dr. Johan Neyts\, Rega Institute Louvain\, Belgium\, specialist of DNA vaccine PLLAV\nDr. Marion Gruber\, FDA\, Director\, Office of Vaccine Research and Review – CBER\nDr. Ivo Classen\, EMA\, Head of Veterinary Medicines Division\nDr. Marco Cavaleri\, EMA\, Head of Anti-infectives and Vaccines\nProf Dr. Jeffery Almond\, Oxford University; Chairman of the Board\, Osivax\nDr. Jean-Christophe Audonnet\, Senior Director\, Vaccines R&D; ZAPI Project Coordinator;\nBoehringer Ingelheim Animal Health\nDr. Emmanuel Hanon\, Senior Vice President\, Head of R&D\, GSK Vaccines\nDr Ajoy Chakrabarti\, Bill & Melinda Gates Foundation Vaccine Development\nDr Steve Black\, The Brighton Collaboration\, Task Force for Global Health\n\nRegister now for the IABS-CEPI Technology Platforms Meeting
URL:https://globalbiodefense.com/event/iabs-cepi-vaccine-technology-platforms-meeting/
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200318T100000
DTEND;TZID=America/New_York:20200318T154500
DTSTAMP:20200210T161026Z
CREATED:20200210T160543Z
LAST-MODIFIED:20200210T161026Z
UID:39238-1584525600-1584546300@globalbiodefense.com
SUMMARY:Next Evolution: Overhauling Key Elements of Biodefense
DESCRIPTION:The Bipartisan Commission on Biodefense will convene a meeting entitled ‘Next Evolution: Overhauling Key Elements of Biodefense‘ on March 18\, 2020 in Washington D.C. and made available by webcast. \nThis meeting aims to inform the assessment of biodefense programs with structural challenges that impede the government’s ability to safeguard the Nation. \nTopics to be discussed at this meeting include the: \n\nSelect Agent Program\nBioWatch Program\nHospital Preparedness Program\n\nSpeakers will share their perspectives\, experiences\, challenges\, and recommended solutions with regard to federal biodetection\, pathogen security\, and hospital preparedness programs. \nRegistration is required and attendance is free. \nWednesday\, March 18\, 2020 \n10:00 AM – 3:45 PM \nHudson Institute \n1201 Pennsylvania Avenue\, NW\, 4th floor \nWashington\, DC 20004 \nSee map \n  \n 
URL:https://globalbiodefense.com/event/next-evolution-overhauling-key-elements-of-biodefense/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200324
DTEND;VALUE=DATE:20200326
DTSTAMP:20200323T210103Z
CREATED:20200319T205750Z
LAST-MODIFIED:20200323T210103Z
UID:42054-1585008000-1585180799@globalbiodefense.com
SUMMARY:BIO Coronavirus Collaboration Initiative Virtual Summit
DESCRIPTION:The Biotechnology Innovation Organization (BIO) is hosting a virtual summit to help companies working on COVID-19 treatments\, diagnostics and vaccines to come together to discuss challenges and opportunities with government officials and other stakeholders. \nThe two-day summit will take place on Tuesday\, March 24 and Wednesday\, March 25\, and will be led by BIO President and CEO Jim Greenwood and Dr. George Scangos\, President and CEO of Vir Biotechnology. BIO Board Chairman Dr. Jeremy Levin\, CEO of Ovid Therapeutics\, appointed Dr. Scangos to oversee the BIO Coronavirus Collaboration Initiative\, which is intended to help connect innovators with partners across both the industry and inside the federal government to combat the coronavirus. \nThe summit will include leaders from biotech and pharmaceutical companies\, global academic experts in virology and immunology\, and non-governmental organizations. Those invited to participate include Ambassador Deborah Birx\, Dr. Robert Kadlec\, and other senior leaders from key government offices\, including the U.S. Department of Defense\, U.S. Department of Health & Human Services\, the Centers for Disease Control and Prevention\, National Institutes of Health\, and the Food and Drug Administration. Information regarding confirmed guests will be provided at a later date. \nAs an international trade association representing more than 700 biotechnology companies\, BIO is playing a unique role in organizing and coordinating the activities of many of its companies. More than 45 member companies are working to address coronavirus and more than 20 have products in various stages of development. \n“Close collaboration between America’s biopharmaceutical companies and the U.S. government is leading the global race to develop vaccines and cures to protect society from the coronavirus\,” said BIO President and CEO Jim Greenwood. “Our researchers and scientists are at the forefront of this important effort\, and they will answer the challenge just as they always have. This virtual summit is a critical step to helping industry leaders\, government officials\, and other vital partners collaborate and ultimately accelerate the development of new medicines to overcome this global threat. BIO is uniquely positioned to help drive this collaboration\, and this is one step in our broader efforts to combat the coronavirus.” \n“Across the biopharmaceutical industry\, men and women are working tirelessly under difficult circumstances to combat the coronavirus\,” said Dr. Scangos.“We are witnessing the true motivation of people in the industry – to do everything we can to bring medicines to people who need them. I am gratified to see people working incredibly hard to bring forward treatments for Covid-19 as quickly as humanly possible. I am pleased to help lead this virtual summit\, which will help facilitate the collaboration and public-private partnerships necessary to treat the sick and prevent further spread of the coronavirus.” \nThe virtual summit will feature presentations and discussions on the latest epidemiologic developments related to the coronavirus\, response work that is underway\, and where critical gaps exist in current R&D and response efforts. The meeting will focus on three key areas of the response: diagnosing the virus\, treating those with the virus\, and preventative measures to contain further transmission of the virus.
URL:https://globalbiodefense.com/event/bio-coronavirus-collaboration-initiative-virtual-summit/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200325T150000
DTEND;TZID=America/New_York:20200325T163000
DTSTAMP:20200325T061035Z
CREATED:20200324T060239Z
LAST-MODIFIED:20200325T061035Z
UID:42230-1585148400-1585153800@globalbiodefense.com
SUMMARY:Responding to COVID-19 Webinar: The Science of Social Distancing
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, The Science of Social Distancing webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \n\n\nBrought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series will explore the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nThe webinar will feature a panel of expert speakers\, including: \n\nNancy Messonnier\, MD — Director\, National Center for Immunization and Respiratory Diseases\, Centers for Disease Control and Prevention\nMarc Lipsitch\, DPhil — Director\, Center for Communicable Disease Dynamics\, Harvard T. H. Chan School of Public Health\nMitch Stripling — National Director\, Emergency Preparedness and Response\, Planned Parenthood and former assistant commissioner of Agency Preparedness and Response for New York City\nHoward Markel\, MD\, PhD — George E. Wantz Distinguished Professor of the History of Medicine and Director of the Center for the History of Medicine\, University of Michigan\n\nThe webinar series will draw from and complement existing advisory activities underway at APHA and the National Academies\, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats\, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19. \nThe series will rapidly and regularly provide trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers\, public health and health care officials\, and the general public. The series will explore the scientific basis for guidance issued by government\, health and public health organizations\, and industry\, as well as answer questions that are top of mind for its audiences.
URL:https://globalbiodefense.com/event/responding-to-covid-19-webinar-the-science-of-social-distancing/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200326
DTEND;VALUE=DATE:20200327
DTSTAMP:20200323T164958Z
CREATED:20200323T164525Z
LAST-MODIFIED:20200323T164958Z
UID:41944-1585180800-1585267199@globalbiodefense.com
SUMMARY:Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness
DESCRIPTION:George Mason University Schar School of Policy and Government Biodefense\, MPP and MPA Programs will co-host a no-fee webinar event\, “Policy vs. Pandemics: Polarization and Public Health Emergency Preparedness” on March 26\, 2020 from 6:00pm – 7:30pm Eastern. \nThe sweeping effects of the on-going COVID-19 pandemic on the social\, economic\, and political framework of the United States highlights the vital importance of a resilient public health infrastructure. In the aftermath of this unprecedented pandemic\, the United States will need to reconsider its approach to biosurveillance\, public health emergency preparedness\, intergovernmental coordination\, and the development of countermeasures in advance of the next health crisis. In the past\, such efforts have been hindered by partisan polarization between Republicans and Democrats\, even as some crucial public health emergency policy was only made possible through bipartisan cooperation. While considering lessons from the past\, this discussion will address bipartisan efforts to move forward on approaches to protect the American people in the future\, such as the implementation of the National Biodefense Strategy. \nDr. Nathan Myers is an associate professor of political science and public administration at Indiana State University. His research interests include public health policy\, U.S. executive branch politics and administration\, emergency planning and preparedness\, and regulation of biotechnology. He is the author of Pandemics and Polarization: Implications of Partisan Budgeting for Responding to Public Health Emergencies (Lexington Books\, 2019). \nDue to the coronavirus pandemic\, this event will be held as a live webinar instead of an in-person talk. Blackboard Collaborate Ultra works best with Google Chrome and does not work with Internet Explorer. Participants will be able to use the “Raise Hand” function in Blackboard Collaborate to ask questions at the end of Dr. Myer’s prepared remarks. \nEveryone who registers for the webinar will receive a 30% discount on his book. \nThis webinar will be recorded and the video will be posted to the YouTube channels for The Pandora Report and the Schar School of Policy and Government . \nIf you have any questions\, please email: biodefense@gmu.edu
URL:https://globalbiodefense.com/event/policy-vs-pandemics-polarization-and-public-health-emergency-preparedness/
LOCATION:Webinar
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200326
DTEND;VALUE=DATE:20200331
DTSTAMP:20200312T210424Z
CREATED:20190928T143345Z
LAST-MODIFIED:20200312T210424Z
UID:30707-1585180800-1585612799@globalbiodefense.com
SUMMARY:CANCELLED: Decennial 2020 - International Conference on Healthcare Associated Infections
DESCRIPTION:Notice from organizers 17 March 2020 \nAfter much deliberation and consideration of the Decennial participants’ substantial role in addressing COVID-19 globally\, the Society for Healthcare Epidemiology of America’s Board of Trustees unanimously decided the 6th Decennial International Conference on Healthcare Associated Infections will no longer occur March 26 – 30\, 2020\, in Atlanta\, GA. Centers for Disease Control and Prevention are in agreement with the decision to cancel. Please be patient with us as we navigate through questions\, concerns\, refunds\, and everything in between. Registered participants can find registration refund information and FAQs on the Attendees/Cancellation FAQs page. \nDecennial 2020 – The 6th International Conference on Healthcare Associated Infections will be held 26-30 March 2020 in Atlanta\, Ga. \nHeld once every ten years\, the Decennial Conference reviews the advances of the previous decade and the opportunities and trends for the fields of healthcare epidemiology\, infectious diseases\, and infection prevention and control for the future. \nTopic areas covered at Decennial 2020 include: \n\nAntimicrobial Stewardship Interventions\nHealthcare-Associated Pneumonia/VAE\nAntimicrobial Stewardship Metrics\nHealthcare-Associated Urinary Tract Infections/CAUTI\nOutbreaks and Clusters\nClostridium difficile\nHealthcare-Associated Bloodstream Infections/CLABSI\nDecolonization Strategies\nHealthcare Preparedness\nDiagnostics/Microbiology\nImplementation Science\nInfection Control in Low and Middle-Income Countries\nPublic Reporting of HAIs/Healthcare Epi Policy\nDisinfection and Sterilization of instruments\nInfections in Immunocompromised Patients Quality Assessment\nEmerging Pathogens\nIntravascular Device-Related Infections\nSurgical Site Infections\nEnvironmental Cleaning and Disinfection\nMedical Informatics\nSurveillance\nFungal Infections\nMethodological and Statistical Issues\nViral Infections\nMultidrug-Resistant Gram-Negative Bacteria\nMolecular Epidemiology\n\nPlease visit the Dicennial 2020 website for more information.
URL:https://globalbiodefense.com/event/decennial-2020-international-conference-on-healthcare-associated-infections/
LOCATION:Atlanta Marriott Marquis\, 265 Peachtree Center Ave NE\, Atlanta\, GA\, 30303\, United States
CATEGORIES:Conference
ORGANIZER;CN="The Society for Healthcare Epidemiology of America (SHEA)":MAILTO:info@shea-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200326T130000
DTEND;TZID=America/New_York:20200326T143000
DTSTAMP:20200324T160955Z
CREATED:20200324T160607Z
LAST-MODIFIED:20200324T160955Z
UID:42206-1585227600-1585233000@globalbiodefense.com
SUMMARY:APIC AIHA Webinar - Ventilation\, Surface Disinfection and PPE Considerations for the IP and IH
DESCRIPTION:Amidst the flood of information about the COVID-19 pandemic\, one of the greatest risks is missing key intelligence that can protect health and save lives. This town hall-style webinar\, co-hosted by AIHA and the Association for Professionals in Infection Control and Epidemiology (APIC)\, will address occupational health and safety professionals’\, industrial hygienists’ and infection preventionists’ questions about ventilation\, surface disinfection\, respirators\, construction issues\, occupational health and safety during the COVID-19 pandemic.\nFull webinar description. \nAre you a 2020 Full eLearning Subscriber? This webinar is included in your subscription.\nIf you are purchasing this registration for another person\, please contact the eLearning staff at 1-703-849-8888. \nREGISTRATION INFORMATION\nEach person interested in attending needs their own registration. If you are unable to participate live\, you will have access to the recording for 90 days\, and you’ll be notified via email once the recording is available in the Online Classroom.When registering\, please only register once. Once you checkout\, the system will prompt you to sign in with your AIHA credentials\, or to create a new account. Once you complete either process\, you will checkout\, verify your information\, and confirm your order. \nDue to an increased volume of registrations\, please allow an hour to receive the confirmation message. You may need to check your junk folder.
URL:https://globalbiodefense.com/event/apic-aiha-webinar-ventilation-surface-disinfection-and-ppe-considerations-for-the-ip-and-ih/
LOCATION:Webinar
CATEGORIES:Conference,Training,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200330
DTEND;VALUE=DATE:20200401
DTSTAMP:20200313T155419Z
CREATED:20200304T182006Z
LAST-MODIFIED:20200313T155419Z
UID:40666-1585526400-1585699199@globalbiodefense.com
SUMMARY:SMi’s 22nd Annual Superbugs & Superdrugs - Remote Access Conference
DESCRIPTION:Due to ongoing concerns over COVID-19 this conference is now available with remote access only \nSMi’s 22nd Annual Superbugs & Superdrugs 2020 Conference will be held  30-31 March 2020. \nA Focus on Non-traditional Approaches in the Fight against Antimicrobial Resistance \nSponsored by Scynexis \nCO-CHAIRS FOR 2020: Cara Cassino\, Chief Medical Officer\, Contrafect & Michael Dawson\, Director\, Mike Dawson Antimicrobial Research Consultancy \nAs one of the most impactful pharmaceuticals for maintaining public health\, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal\, including colistin\, carbapenems\, 3rd and 4th generation cephalosporins\, useless. \nThis year’s event aims to showcase a suite of sessions focused on novel drugs and approaches\, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. \nIt is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR\, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR\, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020\, along with leaders from the pharmaceutical industry\, academia\, regulatory and funding bodies\, and public-private partnerships to discuss the way forward. \nEvent Hashtag: #SMiBugs \nFEATURED SPEAKERS FOR 2020: \n\nYuri Gleba\, Professor\, Founder\, Nomad Bioscience\nMark Albrecht\, Branch Chief\, Antibacterials program\, BARDA/HHS\nPaul Finn\, CEO\, Oxford Drug Design\nCara Cassino\, Chief Medical Officer\, Contrafect\nMartin Everett\, CSO\, Antabio\nSamareh Lajaunias\, Director\, Combioxin SA\nFrancois Moreau\, Scientific Director\, Mutabilis\nEmma Leire\, Microbiology Lead\, Centauri Therapeutics\nLorenzo Corsini\, Co-Founder/CEO/R&D\, Phagomed\nStephen Barat\, VP\, Preclinical Research and Early Development\, Scynexis\nColm Leonard\, Consultant Clinical Adviser/Consultant Thoracic Physician/Honorary Pro\n\nWHATS ON THE AGENDA FOR 2020? \n\nDiscuss the new classes of non-antibiotic antibacterial proteins: Colicins and Colicin-like Bacteriocins from Nomad Bioscience\nGain valuable insight towards fighting severe and resistant infections through neutralising bacterial virulence effectors from Combioxin\nExamine a UK project looking at novel value assessment and reimbursement for novel antimicrobials from NICE/Manchester University NHS Foundation Trust\nExplore direct lytic agents (DLAs) and their potential as a successful disruptive anti-infective technology with Contrafect\nEvaluate the utility of machine learning and AI in antibiotic drug discovery with Oxford Drug Design\n\nGlobal Biodefense is an official media partner of Superbugs & Superdrugs 2020.
URL:https://globalbiodefense.com/event/smis-22nd-annual-superbugs-superdrugs-conference/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/03/superbugs-superdrugs-2020-smi-group.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200408T140000
DTEND;TZID=America/New_York:20200408T153000
DTSTAMP:20200402T171318Z
CREATED:20200402T170907Z
LAST-MODIFIED:20200402T171318Z
UID:42524-1586354400-1586359800@globalbiodefense.com
SUMMARY:NASEM Webinar: The Supply Chain and COVID-19
DESCRIPTION:COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. \nThe National Academies’ Transportation Research Board (TRB) is hosting a webinar on Wednesday\, April 8\, 2020\, from 2:00 to 3:30 PM Eastern that will explore the impacts of COVID-19 on the supply chain and logistics industries. Presenters will discuss lessons learned from past freight transportation and supply chain disruptions\, identify research that has been done to address resilience in the supply chain\, describe how to mitigate the economic impacts of these disruptions\, and provide commentary on current supply chain disruptions due to COVID-19. The webinar is free to attend\, but registration is required. You can follow the conversation on Twitter by using #COVID19 and #TRBwebinar. \nWebinar Participants\n• Moderated by: Mike Meyer\, WSP\, Principal Investigator for NCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\n• Paul Bingham\, IHS Markit\, expert in supply chain logistics\, freight transportation\, and transportation economics\n• Anne Strauss-Wieder\, North Jersey Transportation Planning Authority\, expert in supply chain and freight movement\, transportation policy\, and maritime transportation \nWebinar Outline \n1. How the supply chain industry has responded to past disruptions\n2. Lessons learned from past disruptions and best practices for a resilient supply chain\n3. How supply chain and logistics managers can respond to disruptions from COVID-19\n4. Question and answer session\nThe first 60 minutes of the webinar will be for presentations and the final 30 minutes will be reserved for audience questions. \nResources about supply chain and logistics from TRB: \n\nNCFRP Research Report 39: Freight Transportation Resilience in Response to Supply Chain Disruptions\nE-Circular E-C259: International Transportation and Economic Development Conference 2018\nTR News article: Supply Chain Business Continuity\nTR News article: Aviation’s Evolving Role in a Changing Climate\nTRB Director Neil Pedersen’s message regarding COVID-19
URL:https://globalbiodefense.com/event/nasem-webinar-the-supply-chain-and-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200415T123000
DTEND;TZID=America/Los_Angeles:20200415T140000
DTSTAMP:20240623T231227Z
CREATED:20200408T174031Z
LAST-MODIFIED:20240623T231227Z
UID:42787-1586953800-1586959200@globalbiodefense.com
SUMMARY:Protecting Older Adults from the Harms of Social Isolation and Providing a Continuum of Care During COVID-19
DESCRIPTION:Join Trust for America’s Health (TFAH) on Wednesday\, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. \nThe ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus\, the practice can exacerbate social isolation\, a longstanding issue for this population. \nAttendees will learn about the consequences of social isolation\, how the aging services sector has adapted its delivery models\, promising practices from the field and the importance of working with public health partners to address the needs of older adults.
URL:https://globalbiodefense.com/event/protecting-older-adults-from-the-harms-of-social-isolation-and-providing-a-continuum-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200415T170000
DTEND;TZID=America/New_York:20200415T183000
DTSTAMP:20240623T192248Z
CREATED:20200414T182247Z
LAST-MODIFIED:20240623T192248Z
UID:43055-1586970000-1586975400@globalbiodefense.com
SUMMARY:APHA and National Academy of Medicine Webinar: Crisis Standards of Care During COVID-19
DESCRIPTION:Brought to you by the American Public Health Association and the National Academy of Medicine\, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally\, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health\, infectious disease\, risk communication\, and crisis standards of care. \nWebinar #4: Crisis Standards of Care During COVID-19\nWednesday\, April 15\, 5-6:30 p.m. ET \nThe fourth COVID-19 Conversations webinar will provide an overview of crisis standards of care during a pandemic\, challenges for adapting such standards to rapidly evolving clinical care guidelines\, practical considerations for state health departments and hospital systems\, and ethical considerations for decision-making while enacting crisis standards of care. \nThe expert panel for this webinar includes: \n\nJohn L. Hick\, MD\, is a faculty emergency physician at Hennepin County Medical Center and an Associate Professor of Emergency Medicine at the University of Minnesota Medical School. He serves as the Associate Medical Director for Hennepin County Medical Services and Medical Director for Emergency Preparedness at HCMC. He is medical advisor to the Minneapolis/St. Paul Metropolitan Medical Response System. He also serves the Minnesota Department of Health as the Medical Director for the Office of Emergency Preparedness and Medical Director for Hospital Bioterrorism Preparedness. He is the founder and past chair of the Minneapolis/St. Paul Metropolitan Health Compact\, a 29-hospital mutual aid and planning group. The regional program was recognized with a $2.5 million competitive HHS preparedness grant in 2007. Hick traveled to Greece as part of a 15-member CDC/HHS team to assist with health care system preparations for the 2004 Summer Olympics. He continues to work with HHS and other agencies on issues of hospital surge capacity planning\, adjusted standards of care in disasters\, and preparedness for nuclear terrorism.\n\n  \n\nRebecca E. Gee\, MD\, is the Secretary of the Louisiana Department of Health\, the state’s largest agency with a budget of $14 billion\, and Gratis Assistant Professor at the LSU Schools of Public Health and Medicine. Her oversight responsibilities include public health and other direct service programs for citizens in needs such as behavioral health\, developmental disabilities\, aging and adult services\, emergency preparedness ad the Medicaid program. Her Medicaid expansion work resulted in an additiona 500\,000+ Louisiana residents being newly insured and the launch of a dashboard to measure access to health care services that has become a national model used in other states. She is an OB/GYN\, trained policy expert and previously served as the director of the Birth Outcomes Initiative\, where she led the charge to decrease infant mortality and prematurity statewide — an effort that in part led to a 25% reduction in infant mortality\, an 85% drop in elective deliveries before 39 weeks and a 10% drop in NICU admissions.\n\n  \n\nJeffrey Kahn\, PhD\, MD\, is the is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics and the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. He is also Professor in the Department of Health Policy and Management of the Johns Hopkins Bloomberg School of Public Health. He works in a variety of areas of bioethics\, exploring the intersection of ethics and health/science policy. Kahn has served on numerous state and federal advisory panels and is currently chair of National Academies of Sciences\, Engineering\, and Medicine’s Board on Health Sciences Policy\, and has previously chaired its committee on the Use of Chimpanzees in Biomedical and Behavioral Research; the committee on Ethics Principles and Guidelines for Health Standards for Long Duration and Exploration Spaceflights; and a committee on the Ethical\, Social\, and Policy Considerations of Mitochondrial Replacement Techniques. He also formerly served as a member of the National Institutes of Health Recombinant DNA Advisory Committee. In addition to committee leadership and membership\, he is an elected member of the National Academy of Medicine and an elected Fellow of The Hastings Center. He was also the founding president of the Association of Bioethics Program Directors. He is a co-principal investigator with Berman Institute faculty member Gail Geller\, ScD\, MHS\, on GUIDE: Genomic Uses in Infectious Disease and Epidemics\, an NIH-funded project to study the largely unexplored ethical\, legal and social implications of genomics as applied to infectious disease.\n\n  \n\nLawrence “Larry” O. Gostin\, JD\, directs the O’Neill Institute for National and Global Health Law and is the founding O’Neil Chair in Global Health Law at Georgetown University. He served as associate dean for research at Georgetown Law from 2004-2008 and is professor of medicine at Georgetown University and professor of public health at Johns Hopkins University. He is director of the World Health Organization Collaborating Center on National and Global Health Law. Among his appointed posts at WHO\, he served on the Director-General’s Advisory Committee on Reforming the World Health Organization\, is on the International Health Regulations Roster of Experts and has served on many WHO expert advisory committees including on the Pandemic Influenza Preparedness Framework and on the WHO/Global Fund Blue Ribbon Expert Panel: The Equitable Access Initiative to develop a global health equity framework. He co-chairs the Lancet Commission on Global Health Law. He served on two global commissions to report on the lessons learned from the 2015 West African Ebola epidemic and was senior advisor to the United Nations Secretary General’s post-Ebola Commission. Gostin also served on the drafting team for the G-17 Summit in Tokyo in 2016\, focusing on global health security and universal health coverage.
URL:https://globalbiodefense.com/event/apha-and-national-academy-of-medicine-webinar-crisis-standards-of-care-during-covid-19/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200421T130000
DTEND;TZID=Europe/London:20200421T140000
DTSTAMP:20240623T192624Z
CREATED:20200406T161624Z
LAST-MODIFIED:20240623T192624Z
UID:42642-1587474000-1587477600@globalbiodefense.com
SUMMARY:DASA Biosensing Across Wide Areas Phase 2 Launch
DESCRIPTION:Join the Defence and Security Accelerator for a dial-in on 21 April 2020\, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. \nOne to Ones\nThere will be two opportunities for One to One dial-in sessions with the competition team: \n\nWednesday 21 April 2020 –  2.30pm to 4pm: Three slots available\nThursday 22 April 2020 – 1pm to 3pm: Four slots available\n\nThese pre-bookable 20 minute one to one slots will be with the competition team to discuss questions specific to your proposal. Slots are on a first come\, first serve basis. \nPlease note: \n\na separate link will be sent to you on your ticket confirmation to register for a one to one slot\ndetails of the dial in will be sent before the meeting commences\nif the event is oversubscribed\, we may place a limitation on the number of attendees from a single organisation\n\n// \nREAD MORE: UK Launches Wide-Area Biosensor Competition
URL:https://globalbiodefense.com/event/dasa-biosensing-across-wide-areas-phase-2-launch/
CATEGORIES:Conference,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/04/97aef6bbedcf01db65e877ee6755e43d.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200503
DTEND;VALUE=DATE:20200507
DTSTAMP:20200430T163052Z
CREATED:20190907T221152Z
LAST-MODIFIED:20200430T163052Z
UID:30271-1588464000-1588809599@globalbiodefense.com
SUMMARY:[CANCELLED] ASM Clinical Virology Symposium 2020
DESCRIPTION:“After careful consideration\, ASM’s Clinical Virology Symposium will not be held May 3-6\, 2020. Based on the U.S. Centers for Disease Control and Prevention’s recent recommendation against holding gatherings with 50 or more people for the next eight weeks\, we believe this is the responsible decision and in the best interest of our community.” \nThe 2020 ASM Clinical Virology Symposium will be held May 3–6 in West Palm Beach\, Florida. \nSave the date! Agenda items will be updated as the meeting dates approach. \nThis annual conference covers the latest on microbiome-virome interactions\, RNA sequencing for viral diagnosis\, the challenges and opportunities for a universal influenza vaccine\, and more. \nWatch on demand these industry workshops from the 2019 ASM Clinical Virology Symposium: \n\nDetection of Influenza and Other Respiratory Viruses With The Panther Fusion® Assays\nKathleen Stellrecht; Albany Medical Center\nAddressing the Challenges in the Diagnosis of Lower Respiratory Tract Infections:  The BioFire FilmArray Pneumonia Panel​ ​\nChristine C. Ginocchio; bioMerieux/BioFire\nBioFire Pneumonia Panel: Preparation\, Validation\, and Go Live \nRaul Benavides; Baylor Univeristy Medical Center (Dallas)\nMultiCenter Clinical Trial Study of the Sentosa® SQ HIV Genotyping Assay – A Next Generation Sequencing Test \nBelinda Yen-Lieberman; Cleveland Clinic\nOur Validation Experience: Augusta HIV Map \nRavindra Kolhe; Medical College of Georgia Augusta University\nFilm Array Pneumonia Panel Finding the Best Fit \nSusan Whittier; Columbia University Irving Medical Center\nGetting It Fast vs Getting It Right: Clinician Perspective \nMadison Orsburn; Millard Henry Clinic\nPCR is Better Than RIDT. IDSA Says So – Laboratory Perspective\nGregory Berry; Northwell Health Labs and Long Island Jewish Medical Center\nLaboratory Diagnosis of Bordetella Infections: Rapid\, Direct Detection and Differentiation of B. Pertussis and B. Parapertussis \nJim Dunn; Texas Children’s Hospital\nRapid Detection of Varicella Zoster Virus Central Nervous System Infections\nPreeti Pancholi; The Ohio State University\n\nVisit the 2020 ASM Clinical Virology Symposium website for the latest information.
URL:https://globalbiodefense.com/event/asm-clinical-virology-symposium-2020/
LOCATION:West Palm Beach\, West Palm Beach\, FL\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200520T110000
DTEND;TZID=America/Los_Angeles:20200520T123000
DTSTAMP:20200513T135220Z
CREATED:20200513T135220Z
LAST-MODIFIED:20200513T135220Z
UID:45402-1589972400-1589977800@globalbiodefense.com
SUMMARY:COVID-19 and the Impact on Communities of Color: Our Nation’s Inequities Exposed
DESCRIPTION:The webinar will highlight the disproportionate health and economic impacts the pandemic is having on communities of color and the short- and long-term efforts needed to advance equity in the response to and recovery from the COVID-19 pandemic and future public health emergencies. There will also be a focus on recent federal legislation and state actions in response to COVID-19.
URL:https://globalbiodefense.com/event/covid-19-and-the-impact-on-communities-of-color-our-nations-inequities-exposed/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
END:VCALENDAR